Zefiro Methane, RENK and Talanx on the Move: Three Interesting Stocks Under Review

Zefiro Methane: 250% Upside Potential

Hundreds of thousands of abandoned oil and gas wells lie dormant in the US. Many of them are emitting methane uncontrollably, endangering groundwater, or are now located in the middle of residential areas. Zefiro Methane tracks down such "orphan wells", measures their emissions, and plugs them. Revenue comes from government and private remediation contracts, as well as from the sale of CO₂ credits.

The seriousness of the problem is illustrated by the recent cover story in the regional newspaper "The Bradford Era". The focus was on the well "Warrant 3489 Johnston & Mathews #1" in Bradford, Pennsylvania. What had looked to residents for years as nothing more than a rusty pipe under an orange traffic cone turned out to be a source containing 50% methane. Zefiro's subsidiary Plants & Goodwin (P&G) successfully plugged the orphan well in November 2025, thereby preventing further harm to people and the environment. Of course, media coverage does not automatically generate new orders. However, it has drawn attention to the issue of orphan wells and Zefiro far beyond expert circles—even leading to a visit from "Beverly Hills 90210" actor Jason Priestley and a BBC feature.

The operational foundation, however, is far more important for the company's future stock market performance. Zefiro's subsidiary P&G has been active in the well-remediation business since 1970 and is one of the few providers capable of carrying out large-scale remediation programs using its own specialists and equipment. In Ohio, Zefiro secured a three-year contract worth USD 19.6 million. Added to this is the Wood 12F project, valued at USD 4.5 million, as well as three other projects awarded in June totaling USD 2.4 million.

The partnership with the Well Done Foundation promises an additional boost. The organization is active in 18 US states, and Zefiro now has operational capabilities in 13 states. An initial contract covers 10 drill holes in the Deep Fork National Wildlife Refuge in Oklahoma; 20 more are set to follow in 2027. A shared site in Okmulgee also provides a base for further tenders in one of the most important oil and gas states in the US.

The numbers are now backing up the story as well. In the third fiscal quarter, revenue rose 58% to USD 11.0 million, and gross profit jumped by as much as 153% to USD 2.56 million. The adjusted net loss, on the other hand, shrank from USD 2.05 million to just USD 62,000. After nine months, the company posted record revenue of USD 33 million and adjusted EBITDA of approximately USD 4.25 million. For the full year, management is projecting revenue of more than USD 40 million.

A video presentation featuring Zefiro Methane's CEO Catherine Flax can be found here:

https://youtu.be/nNodjcqNJMM

The Augsburg-based financial services provider GBC Research expects sustained strong growth. For the 2025/26 fiscal year just ended, analysts are projecting revenue of USD 45.18 million and EBITDA of USD 3.73 million. In the current fiscal year, revenue is expected to rise to USD 57.92 million. EBITDA is projected to jump to USD 10.02 million. By 2027/28, revenue could reach USD 66.85 million and EBITDA USD 12.22 million.

According to GBC, the CO₂ credit business has not yet been fully factored into these figures. By plugging leaking wells, Zefiro prevents future methane emissions. Once verified, these savings can be converted into emission credits and sold. This business is currently largely on hold but could resume in the second half of fiscal year 2026/27 following the introduction of a revised calculation method. Since this entails virtually no additional operating costs, above-average margins are expected.

GBC has initiated coverage of the stock with a "Buy" rating and a price target of USD 1.50 (CAD 2.12). Based on the current share price of around USD 0.42 (CAD 0.61), this translates to a potential gain of approximately 250%. That sounds spectacular, but if the company succeeds in translating its recent momentum into sustainable growth and stable profits, the market could completely revalue the stock. Even though the share has already gained more than 100% over the past 12 months, it could very well double again in the medium term. If Zefiro succeeds in further boosting its order backlog and translating the positive EBITDA trend into sustainable profits, today's valuation is likely to leave plenty of room for growth. However, the stock remains highly speculative, and investors should factor in price fluctuations.

RENK: Full Order Books, Patient Shareholders

At the German defense contractor RENK, order intake is growing faster than revenue. In the first half of the year, orders rose by just under 30% to around EUR 1.2 billion. In the second quarter alone, orders totaling EUR 612.8 million were received—more than ever before in a single quarter. The total order backlog reached EUR 7.4 billion, and the ratio of new orders to revenue stood at a robust 1.9.

The defense boom is already making its mark on the income statement, albeit at a more measured pace. Revenue grew by only 2.7% to EUR 637.2 million, but adjusted EBIT rose by a solid 10% to EUR 98.2 million. The margin improved from 14.4% to 15.4%. For 2026, RENK continues to target more than EUR 1.5 billion in revenue and adjusted EBIT of EUR 255 to 285 million. In 2025, just under 64% of revenue came from the vehicle transmission business. RENK has a more international presence than the debate over German defense spending might suggest: only about 24% of revenue came from Germany, just under 29% from Asia, and another 24% from the Americas.

The market consensus continues to expect strong growth from the transmission specialist. Revenue is projected to rise from EUR 1.37 billion in 2025 to EUR 1.56 billion in 2026, EUR 1.81 billion in 2027, and EUR 2.16 billion in 2028. Analysts expect earnings per share to rise from EUR 1.61 to EUR 1.75, EUR 2.17, and finally EUR 2.79. At the same time, free operating cash flow is expected to more than triple, rising from EUR 70 million last year to EUR 150 million in 2026 and up to EUR 220 million in 2028. This would be proof that the boom in orders is indeed translating into cash.

However, this growth does not come cheap. At a share price of around EUR 51, RENK is valued at just over EUR 5.1 billion. The expected P/E ratio for 2026 is just under 30, and the enterprise value is 17 times the projected EBITDA. That is certainly not a bargain. Both multiples are above the industry median. By 2028, however, the P/E ratio would fall below 19 if the estimates are met.

Since its October 2025 high, the stock has also lost more than 45%. The price decline has removed much of the excess from the valuation, but has not yet eliminated the high expectations and execution risks. Analysts remain decidedly optimistic. Currently, 17 banks and research firms recommend a "Buy" rating, while only 2 analysts have issued "Hold" ratings. There are currently no "Sell" recommendations. The median price target of just under EUR 65 offers around 26% upside potential. For long-term investors, RENK remains attractive at current levels. Positions can be increased on weaker trading days.

Talanx: Record Profit at a Reasonable Price

On Friday, the insurer Talanx delivered solid profits rather than promises for the future. Net income rose 9% in the first half of the year to a record EUR 1.50 billion, while operating profit increased 11% to EUR 3.2 billion. The return on equity reached 21.5%, and the combined ratio improved from 90.7% to 88.7%.

Major losses totalling EUR 942 million, nearly half a billion euros below the pro-rated budget, contributed to these results. Talanx has already set aside EUR 200 million for potential liabilities arising from the war in Iran. Following the strong first half of the year, the insurer now expects a net profit of "significantly more" than EUR 2.7 billion in 2026. The Solvency II ratio of 246% indicates a comfortable capital buffer.

The analyst consensus is already higher. On average, financial experts expect a net profit of EUR 2.95 billion and earnings per share of EUR 11.05. At a share price of around EUR 119, Talanx has a market capitalization of approximately EUR 30.7 billion. The expected P/E ratio for the next twelve months is just over 10, which is roughly in line with the industry median. In terms of enterprise value-to-EBITDA, Talanx, with a multiple of around 5, is even significantly cheaper than the sector average of 7.5. Added to this is an expected dividend yield of around 3.9%.

Seven banks and research firms recommend the stock as "Buy", while two analysts rate it as a "Hold". As with RENK, there are currently no "Sell" recommendations. The median price target of just over EUR 133 offers about 12% upside potential.

The low level of major losses cannot simply be extrapolated, especially since the hurricane season will not begin to impact the bottom line until the second half of the year. Talanx, however, impresses with profitable growth, disciplined underwriting, and rising returns on capital. Measured by earnings power, balance sheet quality, and dividends, the share remains attractive. On weak days, the share is a buy for long-term investors.

Talanx stands for predictable quality, RENK for a well-filled order backlog, and Zefiro for speculative growth potential. All three stocks are attractive and promising. The small Canadian environmental services provider holds the greatest potential for surprises: orders are growing, operating income is positive, and the business model is visibly expanding its reach. However, the stock is also the most speculative of the trio.